Q1 EPS Estimates for Aspen Aerogels Raised by Roth Capital

Aspen Aerogels, Inc. (NYSE:ASPN) – Roth Capital boosted their Q1 2025 earnings estimates for shares of Aspen Aerogels in a research note issued to investors on Friday, November 8th. Roth Capital analyst C. Moore now forecasts that the construction company will post earnings of $0.04 per share for the quarter, up from their prior forecast of $0.02. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.23 EPS.

ASPN has been the subject of a number of other research reports. HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. TD Cowen increased their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Barclays dropped their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday. Finally, Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $28.70.

Aspen Aerogels Trading Down 8.5 %

ASPN opened at $15.80 on Monday. Aspen Aerogels has a 12 month low of $8.79 and a 12 month high of $33.15. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The stock has a 50-day moving average of $22.87 and a 200 day moving average of $24.74. The firm has a market cap of $1.22 billion, a P/E ratio of 1,581.58 and a beta of 2.21.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of the business. Point72 Hong Kong Ltd bought a new position in shares of Aspen Aerogels during the second quarter valued at approximately $84,000. nVerses Capital LLC purchased a new stake in Aspen Aerogels during the second quarter worth $95,000. Quent Capital LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at $118,000. Point72 DIFC Ltd purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at $145,000. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.